Fundraising FoxIdosetrhcp
1 known investors
Find your way into Idosetrhcp
Sign up to see every warm intro you have to Idosetrhcp
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Idosetrhcp team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.
Investors · 1
Frequently asked questions
- What does Idosetrhcp do?
- iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.
- Who are Idosetrhcp's investors?
- Idosetrhcp's investors include Avedro, Inc..